Latest Industry Insights

Industry Insight
How CRISPR Is Transforming High-Throughput Screening
This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.

Industry Insight
One-Chip-Fits-All: Biofabrication of Hydrogel Fiber Architectures Using Flow Focusing Microfluidics
This article discusses an innovative biofabrication method that uses a single 3D hydrodynamic flow focusing chip to generate different hydrogel configurations with specific geometries for various biological applications.

Industry Insight
Three Noteworthy Applications of CRISPR
Only 10 years ago, Nobel prize-winning work introduced CRISPR as a new and powerful genome editing tool. Here, three noteworthy applications of the technology are highlighted.

Industry Insight
“Rewriting the Textbook” for Precision Medicine
Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.

Industry Insight
BYOD: The Future of Clinical Trials
BYOD has become an essential cornerstone of modern clinical trials. This article discusses the adoption of BYOD and the benefits it can bring to patients.

Industry Insight
The Battle for Psychedelic Patents
In this article, Technology Networks speaks with Mindset Pharma CEO James Lanthier about how patents work in the fast-changing psychedelics industry, what makes a patent effective and how newer compounds stack up against natural psychedelics.

Industry Insight
Psilocybin Study To Investigate the Serotonin System in Autism
In this interview, we speak to research scientist Tobias Whelan, who is conducting a first-ever mechanistic study of psilocybin in autistic adults to understand how the serotonin system may differ in autistic and non-autistic individuals.

Industry Insight
Preserving the Power of Clinical Data
Chris Sigley highlights some of the main findings from the Ethical Medicines Industry Group and Arkivum’s annual survey tracking the progress of digital transformation and clinical data strategies of 305 global life sciences organizations.

Industry Insight
Broadening the Adoption of Pharmacogenomic Testing
Technology Networks recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.

Industry Insight
A New Approach to T-Cell Therapy
In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.
Advertisement